tryptophan has been researched along with Atherosclerosis in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (22.58) | 29.6817 |
| 2010's | 14 (45.16) | 24.3611 |
| 2020's | 10 (32.26) | 2.80 |
| Authors | Studies |
|---|---|
| Han, YM; Ramprasath, T; Yu, CJ; Zhang, D; Zou, MH | 1 |
| Kuo, CC; Lee, GL; Liao, TL; Wu, JY; Wu, KK | 1 |
| Konopelski, P; Mogilnicka, I | 1 |
| Ding, Y; Huang, H; Li, J; Ouyang, L; Song, P; Su, X; Xie, Z; Xu, Z; Yu, C; Zou, MH | 1 |
| Chen, K; Chen, S; Chen, X; Deng, Y; Ling, W; Xue, H; Yang, Y; Yu, C; Zhang, Y | 1 |
| Ageev, AA; Appolonova, SA; Belenkov, YN; Korobkova, EO; Kozhevnikova, MV; Krivova, AV; Moskaleva, NE; Privalova, EV; Shestakova, KM | 1 |
| Chen, B; Chen, L; Chen, Y; Deng, Y; Feng, Y; Guan, H; Huang, A; Huang, P; Huang, X; Lei, S; Li, Z; Peng, W; Xie, D; Yan, L; Yu, L; Zeng, J; Zhao, S | 1 |
| Cockerham, E; Das, S; Delgadillo, LF; Finney, AC; Kumar, D; Liu, W; Liu, Z; Orr, AW; Pattillo, CB; Rashdan, NA; Razani, B; Rom, O; Seeley, EH; Stroope, C; Traylor, J; Yuan, S; Yurdagul, A | 1 |
| Hermanowicz, JM; Kwiatkowska, I; Mysliwiec, M; Pawlak, D | 1 |
| Gluvic, Z; Isenovic, ER; Obradovic, M; Sudar-Milovanovic, E; Zaric, B | 1 |
| Baumgartner, R; Forteza, MJ; Ketelhuth, DFJ | 1 |
| Liu, JJ; Movassat, J; Portha, B | 1 |
| Atzler, D; Lacy, M; Nitz, K | 1 |
| Ketelhuth, DFJ | 1 |
| Chen, Y; Dai, S; Gordon, J; Kearns, AC; Lehmicke, G; Liu, F; Qin, X; Rappaport, J; Velasquez, S | 1 |
| Ketelhuth, DF; Polyzos, KA | 1 |
| Agardh, H; Assinger, A; Bäck, M; Baumgartner, R; Berg, M; Gisterå, A; Hansson, GK; Ketelhuth, DF; Laguna-Fernandez, A; Ovchinnikova, O; Pirault, J; Polyzos, KA | 1 |
| Cho, KH; Choi, I; Kim, JR; Kim, JY; Park, KH | 1 |
| Cao, Z; Cheng, G; Shi, R; Yang, Y; Zhang, G | 1 |
| Hurme, M; Jula, A; Kähönen, M; Kesäniemi, YA; Lehtimäki, T; Moilanen, L; Nieminen, MS; Niinisalo, P; Oja, SS; Pertovaara, M; Raitala, A; Reunanen, A | 1 |
| Brubaker, G; Hazen, SL; Kinter, M; Peng, DQ; Smith, JD; Willard, B; Wu, Z; Zheng, L | 1 |
| Chantepie, S; Chapman, MJ; Kontush, A; Malle, E; Sattler, W | 1 |
| Hurme, M; Järvinen, O; Kähönen, M; Kytömäki, L; Laaksonen, R; Lehtimäki, T; Levula, M; Niinisalo, P; Oksala, N; Pelto-Huikko, M; Salenius, JP; Soini, JT | 1 |
| Biesecker, LG; Mullikin, JC; Ng, D; Spaulding, E | 1 |
| Chida, K; Fujie, M; Furuhashi, M; Hishida, A; Kato, A; Maruyama, Y; Suda, T; Suzuki, M; Suzuki, Y; Takita, T | 1 |
| Elovainio, M; Hintsa, T; Hintsanen, M; Hurme, M; Jokela, M; Keltikangas-Järvinen, L; Kivimäki, M; Lehtimäki, T; Pulkki-Råback, L; Raitakari, OT; Viikari, J | 1 |
| Ferreira, ST; Jaureguiberry, MS; Prieto, ED; Ramella, NA; Rimoldi, OJ; Sanchez, SA; Schinella, GR; Tricerri, MA; Vela, ME | 1 |
| Ambrosini, A; Bacchetti, T; Bertoli, E; Ferretti, G; Wozniak, M; Zolese, G | 1 |
| Chung, HT; Kim, YM; Lee, BS; Oh, GS; Pae, HO; Rim, JS | 1 |
| Frick, B; Fuchs, D; Schroecksnadel, K; Winkler, C | 1 |
| Alexopoulos, C; Beaufils, C; Coudevylle, N; Cung, MT; Petraki, MP; Sakarellos, C; Sakarellos-Daitsiotis, M; Tselepis, AD | 1 |
10 review(s) available for tryptophan and Atherosclerosis
| Article | Year |
|---|---|
Tryptophan Catabolism and Inflammation: A Novel Therapeutic Target For Aortic Diseases.
Topics: Animals; Anti-Inflammatory Agents; Aorta; Aortic Aneurysm, Abdominal; Aortitis; Atherosclerosis; Humans; Inflammation Mediators; Kynurenine; Signal Transduction; Tryptophan | 2021 |
Biological Effects of Indole-3-Propionic Acid, a Gut Microbiota-Derived Metabolite, and Its Precursor Tryptophan in Mammals' Health and Disease.
Topics: Animals; Atherosclerosis; Bacteria; Cardiovascular Diseases; Gastrointestinal Microbiome; Humans; Indoles; Oxidative Stress; Tryptophan | 2022 |
Oxidative Storm Induced by Tryptophan Metabolites: Missing Link between Atherosclerosis and Chronic Kidney Disease.
Topics: Atherosclerosis; Humans; Metabolome; Models, Biological; Oxidative Stress; Renal Insufficiency, Chronic; Tryptophan | 2020 |
Tryptophan Metabolism in Atherosclerosis and Diabetes.
Topics: Animals; Atherosclerosis; Diabetes Mellitus, Type 2; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Tryptophan | 2022 |
The interplay between cytokines and the Kynurenine pathway in inflammation and atherosclerosis.
Topics: Adaptive Immunity; Animals; Atherosclerosis; Cardiovascular Diseases; Cytokines; Humans; Immunity, Innate; Indoleamine-Pyrrole 2,3,-Dioxygenase; Inflammation; Kynurenine; Tryptophan | 2019 |
Emerging role for kynurenines in metabolic pathologies.
Topics: Aging; Animals; Atherosclerosis; Biomarkers; Diabetes Mellitus; Homeostasis; Humans; Islets of Langerhans; Kynurenine; Metabolic Diseases; Metabolic Networks and Pathways; Obesity; Tryptophan | 2019 |
Amino Acids and Their Metabolism in Atherosclerosis.
Topics: Amino Acids; Animals; Arginase; Arginine; Atherosclerosis; Disease Progression; Endothelial Cells; Endothelium, Vascular; Homoarginine; Humans; Hypercholesterolemia; Indoleamine-Pyrrole 2,3,-Dioxygenase; Lymphocyte Subsets; Molecular Targeted Therapy; Nitric Oxide Synthase; Tryptophan; Vasculitis | 2019 |
The immunometabolic role of indoleamine 2,3-dioxygenase in atherosclerotic cardiovascular disease: immune homeostatic mechanisms in the artery wall.
Topics: Animals; Anti-Inflammatory Agents; Arteries; Atherosclerosis; Energy Metabolism; Humans; Immune System; Immunomodulation; Indoleamine-Pyrrole 2,3,-Dioxygenase; Inflammation; Plaque, Atherosclerotic; Signal Transduction; Tryptophan; Up-Regulation | 2019 |
The role of the kynurenine pathway of tryptophan metabolism in cardiovascular disease. An emerging field.
Topics: Animals; Atherosclerosis; Humans; Kynurenine; Models, Cardiovascular; Plaque, Atherosclerotic; Signal Transduction; Tryptophan | 2015 |
Crucial role of interferon-gamma and stimulated macrophages in cardiovascular disease.
Topics: Animals; Atherosclerosis; Cardiovascular Diseases; Humans; Inflammation; Interferon-gamma; Macrophage Activation; Macrophages; Neopterin; Oxidative Stress; Reactive Oxygen Species; Tryptophan | 2006 |
21 other study(ies) available for tryptophan and Atherosclerosis
| Article | Year |
|---|---|
Restoration of 5-methoxytryptophan protects against atherosclerotic chondrogenesis and calcification in ApoE
Topics: Animals; Atherosclerosis; Calcinosis; Chondrogenesis; Diet, High-Fat; Mice; Tryptophan | 2021 |
Indoleamine 2,3-Dioxygenase 1 Deletion-Mediated Kynurenine Insufficiency in Vascular Smooth Muscle Cells Exacerbates Arterial Calcification.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Core Binding Factor Alpha 1 Subunit; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Mice; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Receptors, Aryl Hydrocarbon; Tryptophan; Vascular Calcification | 2022 |
Gut Microbially Produced Indole-3-Propionic Acid Inhibits Atherosclerosis by Promoting Reverse Cholesterol Transport and Its Deficiency Is Causally Related to Atherosclerotic Cardiovascular Disease.
Topics: Animals; Atherosclerosis; ATP Binding Cassette Transporter 1; Cardiovascular Diseases; Cholesterol; Humans; Indoles; Mice; MicroRNAs; Plaque, Atherosclerotic; Propionates; Tryptophan | 2022 |
Comparative analysis of tryptophan and downstream metabolites of the kynurenine and serotonin pathways in patients with arterial hypertension and coronary artery disease.
Topics: Atherosclerosis; Coronary Artery Disease; Humans; Hydroxyindoleacetic Acid; Hypertension; Kynurenic Acid; Kynurenine; Quinolinic Acid; Serotonin; Tryptophan | 2022 |
Potential shared gene signatures and molecular mechanisms between atherosclerosis and depression: Evidence from transcriptome data.
Topics: Atherosclerosis; Computational Biology; Depression; Gene Expression Profiling; Gene Regulatory Networks; Humans; Lipids; Matrix Metalloproteinase 9; Transcriptome; Tryptophan | 2023 |
Spatially Resolved Metabolites in Stable and Unstable Human Atherosclerotic Plaques Identified by Mass Spectrometry Imaging.
Topics: Atherosclerosis; Humans; Mass Spectrometry; Necrosis; Plaque, Atherosclerotic; RNA; Tryptophan | 2023 |
Elevated indoleamine-2,3-dioxygenase enzyme activity in a novel mouse model of HIV-associated atherosclerosis.
Topics: Animals; Aorta; Aortic Diseases; Atherosclerosis; Cytokines; Diet, High-Fat; Disease Models, Animal; HIV Infections; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Mice, Transgenic; Tryptophan | 2019 |
Inhibition of indoleamine 2,3-dioxygenase promotes vascular inflammation and increases atherosclerosis in Apoe-/- mice.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Inflammation; Kynurenine; Mice, Knockout; Tryptophan; Tunica Media; Vascular Cell Adhesion Molecule-1 | 2015 |
ω-6 (18:2) and ω-3 (18:3) fatty acids in reconstituted high-density lipoproteins show different functionality of anti-atherosclerotic properties and embryo toxicity.
Topics: alpha-Linolenic Acid; Animals; Antioxidants; Apolipoprotein A-I; Atherosclerosis; Cellular Senescence; Circular Dichroism; Fibroblasts; Gene Expression Regulation, Developmental; Humans; Inflammation; Linoleic Acid; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Macrophages; Oxygen; Phagocytosis; Reactive Oxygen Species; Tryptophan; Zebrafish | 2015 |
VPO1 mediates oxidation of LDL and formation of foam cells.
Topics: Animals; Aorta; Atherosclerosis; Cell Line, Tumor; Foam Cells; Humans; Hypochlorous Acid; Immunoblotting; Lipopolysaccharides; Lipoproteins, LDL; Mice; Mice, Inbred C57BL; Oxidation-Reduction; Peroxidases; Thiobarbiturates; Tryptophan; Tumor Necrosis Factor-alpha | 2016 |
Indoleamine 2,3-dioxygenase activity associates with cardiovascular risk factors: the Health 2000 study.
Topics: Adult; Aged; Atherosclerosis; Cardiovascular Diseases; Female; Health; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Male; Middle Aged; Risk Factors; Tryptophan | 2008 |
Apolipoprotein A-I tryptophan substitution leads to resistance to myeloperoxidase-mediated loss of function.
Topics: Amino Acid Substitution; Animals; Apolipoprotein A-I; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Cell Line; Cholesterol; Humans; Hydrogen Peroxide; Lysine; Macrophages; Methionine; Mice; Mutagenesis, Site-Directed; Oxidation-Reduction; Peroxidase; Recombinant Proteins; Tryptophan | 2008 |
Distinct HDL subclasses present similar intrinsic susceptibility to oxidation by HOCl.
Topics: Atherosclerosis; Blood Protein Electrophoresis; Electrophoresis, Agar Gel; Fatty Acids, Unsaturated; Humans; Hypochlorous Acid; In Vitro Techniques; Lipoproteins, HDL; Lipoproteins, HDL2; Lipoproteins, HDL3; Oxidants; Oxidation-Reduction; Tryptophan | 2009 |
Activation of indoleamine 2,3-dioxygenase-induced tryptophan degradation in advanced atherosclerotic plaques: Tampere vascular study.
Topics: Aged; Aged, 80 and over; Antigen-Presenting Cells; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antigens, Differentiation, T-Lymphocyte; Atherosclerosis; CD28 Antigens; CTLA-4 Antigen; Female; Finland; Forkhead Transcription Factors; Gene Expression; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Inducible T-Cell Co-Stimulator Protein; Macrophages; Male; Middle Aged; Monocytes; T-Lymphocytes, Regulatory; Tryptophan | 2010 |
Identification of a novel LDLR mutation (c.261_262invGA, p.Trp87X): Importance of specifying DNA and protein mutations.
Topics: Aged; Atherosclerosis; DNA; Female; Gene Expression Regulation; Genetic Variation; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Mutation; Pedigree; Phenotype; Receptors, LDL; Tryptophan | 2010 |
Relationship between an increased serum kynurenine/tryptophan ratio and atherosclerotic parameters in hemodialysis patients.
Topics: Adult; Aged; Ankle Brachial Index; Atherosclerosis; Carotid Arteries; Female; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kidney Failure, Chronic; Kynurenine; Male; Middle Aged; Renal Dialysis; Time Factors; Tryptophan; Tunica Intima; Tunica Media; Young Adult | 2010 |
Moderating effect of indoleamine 2,3-dioxygenase (IDO) activation in the association between depressive symptoms and carotid atherosclerosis: evidence from the Young Finns study.
Topics: Adult; Atherosclerosis; Carotid Artery Diseases; Depression; Dioxygenases; Female; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Indoles; Kynurenine; Longitudinal Studies; Male; Psychiatric Status Rating Scales; Risk Factors; Sex Factors; Tryptophan; Tryptophan-tRNA Ligase; Women; Young Adult | 2011 |
Human apolipoprotein A-I-derived amyloid: its association with atherosclerosis.
Topics: Amyloid; Anilino Naphthalenesulfonates; Animals; Apolipoprotein A-I; Atherosclerosis; Benzothiazoles; CHO Cells; Cholesterol; Cricetinae; Cricetulus; Heparin; Humans; Hydrogen-Ion Concentration; Hypochlorous Acid; Matrix Metalloproteinase 12; Neutrophil Activation; Oxidation-Reduction; Protein Binding; Protein Folding; Protein Stability; Protein Structure, Quaternary; Protein Structure, Secondary; Proteolysis; Solvents; Tetradecanoylphorbol Acetate; Thiazoles; Tryptophan | 2011 |
Increased plasma concentrations of palmitoylethanolamide, an endogenous fatty acid amide, affect oxidative damage of human low-density lipoproteins: an in vitro study.
Topics: 2-Naphthylamine; Adult; Amides; Apolipoprotein B-100; Apolipoproteins B; Atherosclerosis; Circular Dichroism; Endocannabinoids; Ethanolamines; Fluorescent Dyes; Humans; In Vitro Techniques; Laurates; Lipid Peroxidation; Lipoproteins, LDL; Middle Aged; Nitrosamines; Oxidative Stress; Palmitic Acids; Tryptophan | 2005 |
3-Hydroxyanthranilic acid, one of L-tryptophan metabolites, inhibits monocyte chemoattractant protein-1 secretion and vascular cell adhesion molecule-1 expression via heme oxygenase-1 induction in human umbilical vein endothelial cells.
Topics: 3-Hydroxyanthranilic Acid; Antioxidants; Atherosclerosis; Bilirubin; Chemokine CCL2; Endothelium, Vascular; Free Radical Scavengers; Gene Expression Regulation, Enzymologic; Heme Oxygenase-1; Humans; NF-E2-Related Factor 2; NF-kappa B; Response Elements; Tryptophan; Tumor Necrosis Factor-alpha; Umbilical Veins; Vascular Cell Adhesion Molecule-1 | 2006 |
Conformational study of new amphipathic alpha-helical peptide models of apoA-I as potential atheroprotective agents.
Topics: Amino Acid Sequence; Antioxidants; Apolipoprotein A-I; Atherosclerosis; Circular Dichroism; Drug Design; Humans; In Vitro Techniques; Models, Molecular; Molecular Sequence Data; Nuclear Magnetic Resonance, Biomolecular; Peptides; Protein Conformation; Protein Structure, Secondary; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Thermodynamics; Tryptophan | 2007 |